Cross-company collaboration on a NICE HTA
Seamless collaboration with Delta Hat to deliver NICE & SMC submissions under tight timelines…
HTA scientific advice for a cell therapy in lymphoma
Supporting Global and UK pharma with early dialogue in the UK and France…
Read more from HTA scientific advice for a cell therapy in lymphoma
Post-Brexit access and regulatory landscape slide resource
Developing a succinct yet detailed training resource on the post-Brexit access and regulatory landscape for global roll-out across stakeholders in a Top 20 pharma company…
Read more from Post-Brexit access and regulatory landscape slide resource
Value proposition development for time critical EU commercial launch
Co-creating a compelling payer value proposition with stakeholders across an alliance of three pharma companies…
Read more from Value proposition development for time critical EU commercial launch
Large pre-launch value comms programme delivery
Pre-launch value communications materials delivered on time due to redthread’s diligent project management and proactive content development…
Read more from Large pre-launch value comms programme delivery
Collaborating in better teams, not bigger teams
Close collaboration with our health economics partners at Delta Hat ensured efficient delivery of pre-launch value communications and modelling deliverables…
Read more from Collaborating in better teams, not bigger teams
Payer value proposition in thyroid cancer
Rescuing a PVP initiated by another vendor in 6 weeks to hit critical global launch timings…
MHRA Innovative Licensing and Access Pathway (ILAP) support
Developing an Innovation Passport (IP) application as the first step of the UK Innovative Licensing and Access Pathway (ILAP) process…
Read more from MHRA Innovative Licensing and Access Pathway (ILAP) support
Parallel SMC submissions in breast cancer
Leading parallel abbreviated submissions to achieve successful unrestricted access at target price…
Joint NICE-CADTH early dialogue in rare neurological diseases
Helping our client navigate the new CADTH real-world evidence early dialogue process, in a joint advice process with NICE, provided powerful patient testimony and evidence generation insights…
Read more from Joint NICE-CADTH early dialogue in rare neurological diseases
Internal communications site to deliver brilliant HTA submissions
Client Top 20 pharma company, UK market access team Challenge Our client wanted to support their team in delivering first-in-class…
Read more from Internal communications site to deliver brilliant HTA submissions
Strategic JSC support for a top 20 pharma company
Supporting Global and UK pharma with early dialogue in the UK and France…
Read more from Strategic JSC support for a top 20 pharma company
Cross-company collaboration on a NICE HTA
Seamless collaboration with Delta Hat to deliver NICE & SMC submissions under tight timelines…
HTA scientific advice for a cell therapy in lymphoma
Supporting Global and UK pharma with early dialogue in the UK and France…
Read more from HTA scientific advice for a cell therapy in lymphoma
Post-Brexit access and regulatory landscape slide resource
Developing a succinct yet detailed training resource on the post-Brexit access and regulatory landscape for global roll-out across stakeholders in a Top 20 pharma company…
Read more from Post-Brexit access and regulatory landscape slide resource
Value proposition development for time critical EU commercial launch
Co-creating a compelling payer value proposition with stakeholders across an alliance of three pharma companies…
Read more from Value proposition development for time critical EU commercial launch
Large pre-launch value comms programme delivery
Pre-launch value communications materials delivered on time due to redthread’s diligent project management and proactive content development…
Read more from Large pre-launch value comms programme delivery
Collaborating in better teams, not bigger teams
Close collaboration with our health economics partners at Delta Hat ensured efficient delivery of pre-launch value communications and modelling deliverables…
Read more from Collaborating in better teams, not bigger teams
Payer value proposition in thyroid cancer
Rescuing a PVP initiated by another vendor in 6 weeks to hit critical global launch timings…
MHRA Innovative Licensing and Access Pathway (ILAP) support
Developing an Innovation Passport (IP) application as the first step of the UK Innovative Licensing and Access Pathway (ILAP) process…
Read more from MHRA Innovative Licensing and Access Pathway (ILAP) support
Parallel SMC submissions in breast cancer
Leading parallel abbreviated submissions to achieve successful unrestricted access at target price…
Joint NICE-CADTH early dialogue in rare neurological diseases
Helping our client navigate the new CADTH real-world evidence early dialogue process, in a joint advice process with NICE, provided powerful patient testimony and evidence generation insights…
Read more from Joint NICE-CADTH early dialogue in rare neurological diseases
Internal communications site to deliver brilliant HTA submissions
Client Top 20 pharma company, UK market access team Challenge Our client wanted to support their team in delivering first-in-class…
Read more from Internal communications site to deliver brilliant HTA submissions
Strategic JSC support for a top 20 pharma company
Supporting Global and UK pharma with early dialogue in the UK and France…
Read more from Strategic JSC support for a top 20 pharma company